BioTie Therapies Corp. Interim Report 1 January - 30 September 2012
11/2/2012 7:25:38 AM
July - September 2012
* Biotie completed a directed share issue of EUR 20 million to institutional
and strategic investors.
* Lundbeck made a EUR 10 Million equity investment in Biotie with a 25%
premium and the parties amended the Selincro licensing agreement regarding
territories outside the EU and US.